These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15824381)

  • 21. [Hepatitis B vaccination and multiple sclerosis: from medical uncertainty to compensation for victims].
    Schütze T; Bouvet R; Le Gueut M
    Rev Neurol (Paris); 2014; 170(8-9):520-6. PubMed ID: 24854962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Affinity of antibody anti-HBs in patients after asymptomatic or symptomatic infection with hepatitis B virus and in individuals vaccinated against this virus].
    Radkowski M; Laskus T; Goch A; Slusarczyk J
    Pol Tyg Lek; 1992 Sep 7-14; 47(36-37):790-2. PubMed ID: 1293562
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccinations and risk of central nervous system demyelinating diseases in adults.
    DeStefano F; Verstraeten T; Jackson LA; Okoro CA; Benson P; Black SB; Shinefield HR; Mullooly JP; Likosky W; Chen RT;
    Arch Neurol; 2003 Apr; 60(4):504-9. PubMed ID: 12707063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure.
    Watkins SL; Alexander SR; Brewer ED; Hesley TM; West DJ; Chan IS; Mendelman P; Bailey SM; Burns JL; Hogg RJ;
    Am J Kidney Dis; 2002 Aug; 40(2):365-72. PubMed ID: 12148110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of recombinant hepatitis B virus vaccine in patients with and without chronic hepatitis C virus infection: a case-control study.
    Daryani NE; Nassiri-Toosi M; Rashidi A; Khodarahmi I
    World J Gastroenterol; 2007 Jan; 13(2):294-8. PubMed ID: 17226912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B vaccination and multiple sclerosis: the jury is still out.
    Hernán MA; Jick SS
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):653-5. PubMed ID: 16245367
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatitis vaccines and pediatric multiple sclerosis: does timing or type matter?
    Ness JM; Bale JF
    Neurology; 2009 Mar; 72(10):870-1. PubMed ID: 19092110
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunogenicity of a new, low-cost recombinant hepatitis B vaccine derived from Hansenula polymorpha in adults.
    Kulkarni PS; Raut SK; Patki PS; Phadke MA; Jadhav SS; Kapre SV; Dhorje SP; Godse SR
    Vaccine; 2006 Apr; 24(17):3457-60. PubMed ID: 16530299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus vaccine in chronic kidney disease: improved immunogenicity by adjuvants? A meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    Vaccine; 2012 Mar; 30(13):2295-300. PubMed ID: 22285268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 31. [Vaccinations do not cause multiple sclerosis].
    Menge T
    MMW Fortschr Med; 2015 Oct; 157(17):45. PubMed ID: 26759880
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and long-term durability of intradermal recombinant hepatitis B virus vaccine among intramuscular vaccine nonresponders: A prospective study in healthcare personnel.
    Kalchiem-Dekel O; Grupel D; Bouchnik L; Sikuler E; Ben-Yakov G
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1782-7. PubMed ID: 26101816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination.
    Mikaeloff Y; Caridade G; Assi S; Tardieu M; Suissa S;
    Brain; 2007 Apr; 130(Pt 4):1105-10. PubMed ID: 17276994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B antiviral resistance and vaccine escape: two sides of the same coin.
    Torresi J
    Antivir Ther; 2008; 13(3):337-40. PubMed ID: 18572745
    [No Abstract]   [Full Text] [Related]  

  • 35. School-based hepatitis B vaccination programme and adolescent multiple sclerosis.
    Sadovnick AD; Scheifele DW
    Lancet; 2000 Feb; 355(9203):549-50. PubMed ID: 10683009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of the "isolated anti-HBc" serological pattern determinated by the serological response to the vaccination against Hepatitis B].
    Coz Yataco A; Lozano Miranda A; Samalvides Cuba F; Antunez de Mayolo Ramis E
    Rev Gastroenterol Peru; 2005; 25(3):254-8. PubMed ID: 16237469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-responders to hepatitis B vaccination: a review.
    Kubba AK; Taylor P; Graneek B; Strobel S
    Commun Dis Public Health; 2003 Jun; 6(2):106-12. PubMed ID: 12889288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Western blot analysis of the reactivity between envelope proteins of hepatitis B viruses from Brazilian carriers and antibodies raised against recombinant hepatitis B vaccines.
    De Castro L; Yoshida CF; Gaspar AM; Gomes SA
    Acta Virol; 1996; 40(5-6):251-8. PubMed ID: 9171452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B vaccination and the risk of multiple sclerosis.
    Ascherio A; Zhang SM; Hernán MA; Olek MJ; Coplan PM; Brodovicz K; Walker AM
    N Engl J Med; 2001 Feb; 344(5):327-32. PubMed ID: 11172163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute transverse cervical myelitis following hepatitis B vaccination. Evolution of anti-HBs antibodies].
    Renard JL; Guillamo JS; Ramirez JM; Taillia H; Felten D; Buisson Y
    Presse Med; 1999 Jul 3-10; 28(24):1290-2. PubMed ID: 10442059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.